Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 13 Feb 23 424B4 Prospectus supplement with pricing info
- 10 Feb 23 EFFECT Notice of effectiveness
- 20 Jan 23 S-1/A IPO registration (amended)
- 4 Nov 22 S-1/A IPO registration (amended)
- 7 Oct 22 S-1/A IPO registration (amended)
- 13 May 22 S-1/A IPO registration (amended)
-
10 May 22 S-1/A IPO registration (amended)
- 29 Apr 22 S-1 IPO registration
BLAC similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Amendment No. 1 to Form S-1, of our report dated April 29, 2022, relating to the financial statements of Bellevue Life Sciences Acquisition Corp., which is contained in that Prospectus. We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC |
New York, New York |
May 9, 2022 |